INTRODUCTION
Gallstones (GS) are a major cause of morbidity and mortality throughout the world [1]. Gallstone disease (GSD) is responsible for about 10,000 deaths per year in the United States. About 7000 deaths are attributed to acute GS complications, such as acute pancreatitis. About 2000-3000 deaths are caused by gallbladder cancers (80% of which occur in the setting of gallstone disease with chronic cholecystitis) [2] . The prevalence of GS in patients with chronic liver disease (CLD) is 20-40%, while it is 10-15% among the general population [3] . Moreover, the incidence of gallstones increased significantly with the progression of liver disease [4] . In Eygpt, it was found that the prevalence of GSD in patients with CLD was 21.8% [5] . GSD is a multifactorial disease based on a complexinteraction of environmental and genetic factors. Gallstones are principally formed due to abnormal bileconstituents (eg, cholesterol, phospholipids and bilesalts) [6] . When bile is concentrated in the gallbladder, it can become supersaturated with such substances, which then precipitate as microscopic crystals. The crystals are trapped in gallbladder mucus, producing gallbladder sludge. Over time, the crystals grow, aggregate, and fuse to form macroscopic stones [7] . Moreover, the increase in gall bladder wall thickness by hyperemia, edema, decreased contractility or impaired gallbladder emptying contributes to gallstone formation [8] .
The most accurate and non-invasivemethod of predicting gallstone disease was achieved with the advent of the ultrasound, which has a sensitivity and a specificity of greater than 95%. However, the true prevalence of the disease remains hard toderive as the majority of patients remain asymptomatic.
According to the NIH guidelines, removal of thegallbladder is the treatment of choice for symptomatic GSD [9] . However, less focus has been directed on patient selection and typical or common symptom characteristics of this disease.
The primary aim of this study is to determine the frequency of cholelithiasis in CLD patients admitted to Zagazig university hospitals. The secondary aim is to determine the risk factors and their association with the underlying etiology and severity of liver disease.
PATIENTS AND METHODS
The study included 131 patients with CLD who were selected from Zagazig University hospitals from May to December, 2013. The study was approved by the local institutional review board. Informed consent was provided by all participants.
For each patient; demographic, clinical and etiological data were recorded by using a precoded questionnaire. A number of laboratory tests as fasting plasma glucose, total cholesterol, triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), hepatitis B surface antigen (HBsAg), and antibody to hepatitis C virus (HCV-Ab) were analyzed. All patients underwent ultrasound abdominal scanning.Ultrasonographic findings suggesting cirrhosis include; hypertrophy of the caudate lobe with concomitant atrophy of the posterior segments of the right lobe, coarse and heterogeneous echo texture, portal vein diameter> 13 mm, splenomegaly, and ascites Patients were subsequently classified into compensated group (N=22 patients) and decompensated group (N= 109 patients). Decompensation means cirrhosis complicated by one or more of the following features; jaundice, ascites, hepatic encephalopathy, bleeding varices, hepatorenal syndrome, hyponatremia and spontaneous bacterial peritonitis.
Statistical analysis:
The Sample size was calculated using Epi info version 6.04. According to the statistical data, the average total number of registered patients was 1500 patient per year, and the prevalence of cholelithiasis was 40 %in CLD patients in the study of Acalovschi et al. [8] at confidence interval 95%, and the power was 80%. Our study included 131patients. We used SPSS (Statistical package for social science) version 21 to obtain descriptive statistics that were calculated in the form of: A) Mean ± Standard deviation (SD) for quantitative parametric data, B) Median and range for quantitative non-parametric data, C) Frequency (Number and percent) for qualitative data. Significance level for all statistical tests has a threshold of significance is fixed at 5% level (p-value).
RESULTS
This study included 131 patients with CLD; Their mean age was 52.9, SD (±11.7) years. There were 55 (42%) males and 76 (58%) females. Chronic HCV infection was found in 101 (77%) patients and 21 (16%) had chronic HBV infection. Table ( 1) summarizes the demographic and clinical characteristics of patients included in the study. The clinical presentation of the patients included in the study was summarized in Table ( 2).
The prevalence of cholelithiasis in the examined patients was 50.4% (66 of 131 patients). Our study showed that Cholelithiasis is more associatied with decompensated than compensated liver diseases (54.1% Vs 30.4%; p value <0.05).
In compensated patients with cholelithiasis; the mean serum Direct bilirubin level was significantly lower than in patients without cholelithiasis (3.5mg/dL vs 0.5mg/dL, p value = 0.031).Other factors including AST, ALT, GGT, cholesterol and TG were not significantly associated with cholelithiasis.
In decompensated patients with cholelithiasis; the mean serum cholesterol and TG level was significantly lower than in patients without cholelithiasis (179mg/dL vs 155mg/dL, p value <0.001) and (109mg/dL vs 91mg/dL, p value = 0.017) retrospectivly. There was no statistically significant difference between ultrasonographic finding of cholelithiasis in compensated and decompensated patients in term of CBD, number and size of gallbladder stones (p value > 0.05) ( Table 3 ).
There was no statistically significant difference between patients with or without cholelithiasis in term of spontaneous bacterial peritonitis, hepatic encephalopathy, hematemesis and melena (p value > 0.005) ( Table 4 ).
The etiology of liver disease did not differ significantly between theose patient with or without cholelithiasis. Common causes included HCV infection, HBV infection and autoimmune disease (p value > 0.05) ( Table 5 ).
The prevalence of cholelithiasis increased with the severity of the disease according to ChildPough classification as the fellowing; In ChildPugh A (10.6%), Child-Pugh B (21.2%), and in Child-Pugh C ( 68.2%). For all child-pugh grades, the difference between patients with or without cholelithiasis was statistically significant (p value = 0.004) as shown in Table ( 6).
The risk of cholelithiasis increased in patients with liver disease who were smokers, diabetic or have a history of contraceptive pills intake (OR= 0.86, 4.71 and 18.69 retrospectively. Diabetis mellitus and history of contraceptive pills intake have a significant association with cholelithiasis (p value > 0.001) ( Table 7 ).
In the compensated group; we found three patients with cholecystitis. Two of them developed obstructive jaundice and one patient had Cholangitis. While, in decompensated group; we found seven patients with cholecystitis. Two of them developed obstructive jaundiceand onepatient had Cholangitis. Obstructive jaundice and cholecystitis showed a statistically significant increase in the compensated group (p value >0.008). 
DISCUSSION
Gallstone disease is a multifactorial disease based on a complexinteraction of environmental and genetic factors. The incidence rate of gallstones in the general populationwas found to be 0.60% per year. The current systematic review of Shabanzadeh et al. additionally identified some dietary factors,comorbidities, and parity to be positively associated and consumptionof coffee, fish, and whole meal bread to haveinverse associations to incident gallstones [13] . Impaired gallbladder contractility as in cirrhosis was found to be in direct relation with the severity of liver disease.
The current study revealed 66 patients with cholelithiasis out of 131 patients with chronic liver disease with a proportion 50.4%. This prevalence is higher than the previously reported in an Egyptian study by Eljaky et In this study, female predominance among patients with cholelithiasis was statistically significant in the compensated group (p=0.006). The high frequency of cholelithiasis in compensated females may be due to childbearing age of these females which explain excessive secretion of cholesterol into bile under the influence of estrogen. Therefore, the incidence of gallstones in women is significantly reduced after menopause due to decline in estrogen levels [16] .
Our result revealed that 28.6% compensated patients with cholelithiasis had diabetes mellitus versus 18.8% without cholelithiasis. Also, 59.3% of decompensated patients with cholelithiasis had diabetes mellitus versus 26% without cholelithiasis. This results is consistent with the study of Shizuka et al., which proved a higher incidence of GSD in diabetics and explained that by the disturbed lipid profile and diminished gall bladder motility in diabetic patients [17] . Moreover, advanced liver disease may add to the disturbed lipid profile and also associated with disturbed glucose homeostasis [18] .
The body mass index of compensated patients with cholelithiasis showed a statistically significance increase in comparison with patients without cholelithiasis, suggesting that obesity is a risk factor for cholelithiasis. This result is consistent with the study of Sahi et al. which reported that obese subjects (BMI >30 kg/m2) are at twice the risk of gallbladder disease than those with a normal BMI [19] .
The history of contraceptive pills usage was frequently reported among female patients with cholelithiasis in decompensated group with a statistically significant pattern when compared to females with no history of contraceptive pills usage (p<0.001). This result was consistent with the study of Cirillo et al. which proved that women on long term oral contraceptives have a two folds increased incidence of cholelithiasis over controls and postmenopausal women taking estrogen-containing drugs have a significant increase frequency (around 1.8 times) of cholelithiasis [20] .
It was reported that gallstones are twice as common in CLD with portal hypertension due to prolonged congestion and increase in venous hydrostatic pressure, which results in edema of the gallbladder and reduce gallbladder contractility [21] .
As regard complication of cholelithiasis among our compensated and decompensated patients. Obstructive jaundice and cholecystitis showed statistically significant increase in compensated group. This finding is consistent with Acalovschi et al. suggesting that hypo-contractility could promote gallstone formation in advanced stage of liver disease.
Regarding to the etiology of CLD in patients with and without cholelithiasis, out result showed that hepatitis C in the most common cause for cholelithiasis (75.8%) followed by hepatitis B (13.6%) and autoimmune disease(1.5%).This result is consistent with the study of Eljaky et al., which proved that the prevalence of GSD in patients with chronic HCV infection was 24.7% versus 10.4% in patients with chronic hepatitis B infection [5] . The high prevalence of gall stones in patients with chronic HCV infection may be attributed to HCV which was detected in the biliary epithelium and it may potentially impair gall bladder function and contribute to gall stone formation [22] .
CONCLUSION
The higher incidence of cholelithiasis in CLD appears to be associated with HCV infection, portal hypertension, gallbladder stasis, and obesity. The risk is increased with the severity of CLD. This is an important parameter to be considered in a country with high prevalence of HCV as Egypt.
